KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | -100.0% | 100 | -99.6% | 0.00% | -100.0% |
| Q3 2017 | $164,000 | -10.4% | 23,040 | -9.1% | 0.01% | -25.0% |
| Q2 2017 | $183,000 | +2187.5% | 25,342 | +1698.6% | 0.01% | +1100.0% |
| Q4 2016 | $8,000 | -86.2% | 1,409 | -88.6% | 0.00% | -66.7% |
| Q1 2016 | $58,000 | -70.1% | 12,412 | -67.7% | 0.00% | -72.7% |
| Q4 2015 | $194,000 | +676.0% | 38,377 | +1818.8% | 0.01% | +1000.0% |
| Q1 2015 | $25,000 | -28.6% | 2,000 | -11.5% | 0.00% | -50.0% |
| Q2 2014 | $35,000 | – | 2,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |